Zonova
Antimicrobial technology embedded into your medical devices.
London, United Kingdom · Founded 2023 · $2.6M raised
- Headquarters
- London
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- zonova.com
- Total Funding
- $2.6M
- Last Round
- $2.6M SeedMay 2026
- Rounds
- 1
About
Zonova is a London-based MedTech company dedicated to eliminating healthcare-associated infections (HAIs) at the source. Founded in 2023 by Dr Georgia Fleet and Carla Southworth, Zonova has developed a proprietary antimicrobial material platform called Z-ROS® that integrates directly into the polymers used in medical device manufacturing — including catheters, IV lines, and breathing tubes. These plastic surfaces are responsible for an estimated 70% of all hospital-acquired infections. By embedding antimicrobial protection at the point of manufacture rather than applying surface coatings, Zonova prevents bacterial growth without relying on antibiotics, offering a front-line defense against antimicrobial resistance. The company raised a £2.1 million seed round in 2026 led by THENA Capital and was awarded the 2026 MedTech Innovator Vision Award. Zonova's technology is applicable across both human health and animal health markets.
Summary
Zonova is a Biotech company based in London, United Kingdom, founded in 2023. It has raised $2.6M in total across 1 round, most recently a $2.6M Seed round in May 2026. Investors include THENA Capital, Angel Academe and Araya Ventures.
Funding History
May 2026
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company

Specialty pharmaceutical company